CVS has agreed to pay $315 million (about £236 million) to settle US government claims that it put corporate profits ahead of patient safety, flooding communities with dangerous opioid combinations that, in some cases, killed the patients who filled them.
The Justice Department announced the civil settlement on 13 October, resolving a nationwide case it first brought in December 2024.